Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025
Lifecore Biomedical (NASDAQ: LFCR) will report financial results for the three months ended September 30, 2025 on Thursday, November 6, 2025 after market close.
Management will host a live webcast at 4:30 p.m. Eastern Time the same day to discuss results. To listen live or access the archived webcast (available for 30 days), visit the company’s Investor Events & Presentations page: https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) comunicherà i risultati finanziari del trimestre chiuso al 30 settembre 2025 il giovedì 6 novembre 2025 dopo la chiusura del mercato.
La direzione terrà una webcast in diretta alle 16:30 ora orientale lo stesso giorno per discutere i risultati. Per ascoltare in diretta o accedere all'archivio della webcast (disponibile per 30 giorni), visitare la pagina Investitori – Eventi e Presentazioni dell'azienda: https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) informará los resultados financieros del trimestre finalizado el 30 de septiembre de 2025 el jueves 6 de noviembre de 2025 después del cierre de la mercado.
La dirección realizará una transmisión web en vivo a las 4:30 p.m. hora del Este ese mismo día para discutir los resultados. Para escuchar en vivo o acceder a la transmisión archivada (disponible durante 30 días), visite la página de Eventos y Presentaciones para Inversionistas de la empresa: https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR)는 2025년 9월 30일에 종료된 분기의 재무 실적을 2025년 11월 6일 목요일 장 마감 후 공개합니다.
경영진은 같은 날 동부 표준시 오후 4시 30분에 생 webcast를 진행하여 결과를 논의할 예정입니다. 라이브를 듣거나 보관 webcast( 30일 동안 이용 가능)에 접속하려면 회사의 투자자 이벤트 및 발표 페이지를 방문하십시오: https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ : LFCR) publiera les résultats financiers du trimestre clos au 30 septembre 2025 le jeudi 6 novembre 2025 après la clôture du marché.
La direction animera une webcast en direct à 16 h 30, heure de l'Est le même jour pour discuter des résultats. Pour écouter en direct ou accéder à la webcast archivée (disponible pendant 30 jours), veuillez consulter la page Investisseurs – Événements et Présentations de l'entreprise : https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (NASDAQ: LFCR) wird die finanziellen Ergebnisse für das Quartal bis zum 30. September 2025 am Donnerstag, dem 6. November 2025 nach Börsenschluss berichten.
Die Geschäftsführung wird am selben Tag um 16:30 Uhr Eastern Time einen Live-Webcast veranstalten, um die Ergebnisse zu besprechen. Um live zuzuhören oder auf den archivierten Webcast zuzugreifen (verfügbar für 30 Tage), besuchen Sie bitte die Seite Investor Events & Presentations des Unternehmens: https://ir.lifecore.com/events-presentations.
Lifecore Biomedical (التداول في ناسداك: LFCR) ستعلن عن النتائج المالية للثلاثة أشهر المنتهية في 30 سبتمبر 2025 يوم الخميس 6 نوفمبر 2025 بعد إغلاق السوق.
ستستضيف الإدارة بثاً مباشراً عبر الويب في الساعة 4:30 مساءً بتوقيت المنطقة الشرقية في اليوم نفسه لمناقشة النتائج. للاستماع المباشر أو الوصول إلى البث المسجّل (متاح لمدة 30 يوماً)، تفضل بزيارة صفحة فعاليات المستثمرين والعروض التقديمية للشركة: https://ir.lifecore.com/events-presentations.
- None.
- None.
Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern
CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the three months ended September 30, 2025, on Thursday, November 6, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss the results.
To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) 415-675-7402 tbrons@vidasp.com Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244 ryan.lake@lifecore.com
FAQ
When will Lifecore Biomedical (LFCR) report Q3 2025 results?
What time is the Lifecore (LFCR) webcast on November 6, 2025?
Where can investors access the Lifecore (LFCR) live webcast and replay?
Will Lifecore (LFCR) management discuss the Q3 2025 results live?
Is the Lifecore (LFCR) archived webcast available immediately after the live event?
